http://www.ft.com/companies/pharmaceuticalshttp://www.ft.com/rss/companies/pharmaceuticalsFT.com - Pharmaceuticalsen© Copyright The Financial Times Ltd 2009. "FT" and "Financial Times" are trademarks of the Financial Times. See http://www.ft.com/servicestools/help/terms#legal1 for the terms and conditions of reuse.client.support@ft.com (Client Support)Fri, 20 Nov 2009 20:39:24 +0000Sun, 22 Nov 2009 01:08:50 +0000Newspapers15http://news.ft.com/cms/d1f3ce1a-6bbe-11da-bb53-0000779e2340.gifhttp://www.ft.com/companies/pharmaceuticals(PICS-1.1 "http://www.classify.org/safesurf/" L gen true for "http://www.ft.com/" r (SS~~000 1))http://traxfer.ft.com/cms/s/0/d6e0a888-d606-11de-b80f-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/d6e0a888-d606-11de-b80f-00144feabdc0.htmlJohnson & Johnson defends its strategy, with its three broad divisions of medical devices, consumer health and pharmaceuticals, even as the approach fails to shield it from industry painsFri, 20 Nov 2009 20:39:24 +0000http://traxfer.ft.com/cms/s/0/5378cf2e-d544-11de-81ee-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/5378cf2e-d544-11de-81ee-00144feabdc0.htmlThe watchdog reassures consumers that it is 'extremely rare' to receive counterfeit drugs from a registered pharmacy or other legitimate outlet Thu, 19 Nov 2009 22:43:34 +0000http://traxfer.ft.com/cms/s/0/84f26952-d427-11de-990c-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/84f26952-d427-11de-990c-00144feabdc0.htmlReduced prices in its main Irish markets have crimped sales growth at the healthcare products supplier, in spite of strong growth in its contract sales and drug packaging businessesThu, 19 Nov 2009 01:54:51 +0000http://traxfer.ft.com/cms/s/0/f32e2cb4-d2fe-11de-af63-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/f32e2cb4-d2fe-11de-af63-00144feabdc0.htmlThe NicVAX vaccine moved closer to the market after a deal between GlaxoSmithKline and the US biotech company Nabi Pharmaceuticals, which developed the productMon, 16 Nov 2009 22:32:56 +0000http://traxfer.ft.com/cms/s/0/c2652114-d20e-11de-a0f0-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/c2652114-d20e-11de-a0f0-00144feabdc0.htmlThe UK-based pharmaceutical group has set a target to cut by two-thirds the waste generated by medicines production Sun, 15 Nov 2009 22:23:34 +0000http://traxfer.ft.com/cms/s/0/3f89e3ac-d07d-11de-af9c-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/3f89e3ac-d07d-11de-af9c-00144feabdc0.htmlA small cluster of British drug companies is marketing drugs that are decades old, relying on consumers' affection for products that they probably first saw in their grandparents' medicine chestSat, 14 Nov 2009 00:21:16 +0000http://traxfer.ft.com/cms/s/0/a4b21910-cf2a-11de-8a4b-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/a4b21910-cf2a-11de-8a4b-00144feabdc0.htmlFour financial investors, along with Israel's Teva, France's Sanofi-Aventis and the US's Pfizer, have submitted bids for the world's fourth-largest generic drugs groupThu, 12 Nov 2009 02:00:00 +0000http://traxfer.ft.com/cms/s/0/8160413a-cd7c-11de-8162-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/8160413a-cd7c-11de-8162-00144feabdc0.htmlThe venture capital model has hampered efforts to create a thriving stem cell sector in the UK and wasted the chance to steal a march on the US, says Jonathan Guthrie Mon, 9 Nov 2009 23:21:20 +0000http://traxfer.ft.com/cms/s/0/f79f8b28-cd4d-11de-8162-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/f79f8b28-cd4d-11de-8162-00144feabdc0.htmlSimultaneous vaccination against seasonal and pandemic flu provides protection against the virus without provoking significant side effects, according to a clinical study released by GlaxoSmithKlineMon, 9 Nov 2009 23:10:21 +0000http://traxfer.ft.com/cms/s/0/ae01c6a6-c9f2-11de-a5b5-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/ae01c6a6-c9f2-11de-a5b5-00144feabdc0.htmlA full half-year of contributions from Protherics boost revenues at the biotechnology group as it looks forward to the direct marketing of two major drugs in the US next yearFri, 6 Nov 2009 05:14:54 +0000http://traxfer.ft.com/cms/s/0/eaf6cd58-ca39-11de-a3a3-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/eaf6cd58-ca39-11de-a3a3-00144feabdc0.htmlSouth Korean prosecutors suspect that they Swiss drugs group illegally provided swine flu treatment to staff of HSBC and Novartis amid fears of a widespread outbreak Thu, 5 Nov 2009 18:49:41 +0000http://traxfer.ft.com/cms/s/0/1481e298-c977-11de-a071-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/1481e298-c977-11de-a071-00144feabdc0.htmlWith a smaller slice of a shrinking domestic pie, Japanese pharmaceutical companies have had to take the fight abroad. The country's track record outside manufacturing does not bode well, but it is too soon to dismiss the industry, writes David Pilling Wed, 4 Nov 2009 20:04:13 +0000http://traxfer.ft.com/cms/s/0/d4af5df8-c8ae-11de-8f9d-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/d4af5df8-c8ae-11de-8f9d-00144feabdc0.htmlThe head of the pioneering tie-up between GlaxoSmithKline and Pfizer predicts the company can operate for at least five years without new funding from shareholdersTue, 3 Nov 2009 22:52:55 +0000http://traxfer.ft.com/cms/s/0/d3edd97a-c88c-11de-a69e-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/d3edd97a-c88c-11de-a69e-00144feabdc0.htmlJohnson & Johnson will cut up to 7% of its 117,000 employees by 2011 as it reduces costs in an effort to weather the global downturn and increase spending on new products.Tue, 3 Nov 2009 21:39:51 +0000http://traxfer.ft.com/cms/s/0/c57f87a4-c8a9-11de-8f9d-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fpharmaceuticalshttp://www.ft.com/cms/s/0/c57f87a4-c8a9-11de-8f9d-00144feabdc0.htmlNovartis plans to inject $1bn into growing its Shanghai laboratories, which would employ 1,000 scientists, and tap China's scientific baseTue, 3 Nov 2009 19:05:00 +0000